Resources

PATH's TB/HIV Project in Tanzania spearheads the scale-up of tuberculosis (TB) and HIV services in four different regions of the country. The project works in collaboration with the National TB and Leprosy Programme, the National AIDS Control Programme, the Association of Private Health Facilities in Tanzania, the US Agency for International Development, US Centers for Disease Control and Prevention, and other stakeholders. This article is a snapshot of PATH's TB/HIV work in Tanzania.

PATH, with support from the President's Emergency Plan for AIDS Relief (PEPFAR), the Global Fund, and the Capacity Project, is currently working in Kenya to scale up tuberculosis and HIV activities in 15 districts and at the national level. This fact sheet details PATH's achievements in the field, with a special focus on community involvement.

This four-page brochure describes PATH's work in tuberculosis, including our project portfolio, project locations, and key partners.

Influenza viruses present one of the major infectious disease threats to the human population, with the recently emerging, highly pathogenic avian influenza strain, H5N1, causing particular concern. A virulent influenza pandemic has the potential to kill more than 100 million people worldwide. This paper analyzes the current supply of influenza vaccines, the predicted demand for influenza vaccines in case of a pandemic, and new vaccine technologies that could provide for the world’s demand in a pandemic situation.

This document is the first annual report to donors on PATH's use of flexible funding (the "Catalyst Fund") and includes highlights of our work to pursue state-of-the-art diagnostic tools for low-resource settings, strengthen avian influenza prevention in countries at high risk of epidemics, and move forward with a fortified rice premix that is being adopted in several countries in Asia.